Serge Saxonov - Nov 22, 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Stock symbol
TXG
Transactions as of
Nov 22, 2023
Transactions value $
-$325,567
Form type
4
Date filed
11/27/2023, 06:15 PM
Previous filing
Nov 16, 2023
Next filing
Dec 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$163K -3.76K -0.44% $43.34 851K Nov 22, 2023 Direct F1
transaction TXG Class A Common Stock Sale -$163K -3.72K -0.44% $43.72 847K Nov 24, 2023 Direct F2
holding TXG Class A Common Stock 27 Nov 22, 2023 See footnote F3
holding TXG Class A Common Stock 870 Nov 22, 2023 See footnote F4
holding TXG Class A Common Stock 183K Nov 22, 2023 See footnote F5
holding TXG Class A Common Stock 16.3K Nov 22, 2023 See footnote F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 This transaction was executed in multiple trades at prices ranging from $43.65 to $43.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F6 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.